Cancer Management Trends for Self-Funded Employers
NantHealth / Eviti
America/New York GMT -4 summer
Approximately 60 percent of U.S. companies are partially or fully self-funding their health plans. With more than a third of Americans being diagnosed with cancer at some point in their lifetime, and injectable drugs for cancer being among the most expensive, cancer continues to be one of the costliest stop-loss claims for these self-insured employers.
Today, self-insured companies are seeking management strategies for oncology care after taking similar steps in cardiology, orthopedics, and other high-cost areas. As they continue to navigate providing healthcare for their workers while considering the costs, understanding more about cancer care will be a crucial component to gaining additional value for their spend.
Join us during this informative webinar to learn more about:
-Why oncology management is vital for self-funded employers
-How employers can take charge of their cancer spend
-Shifts and evolutions experienced by self-funded employers
Register today for our free webinar, Cancer Management Trends for Self-Funded Employers
Why oncology management is vital for self-funded employers, How employers can take charge of their cancer spend, Shifts and evolutions experienced by self-funded employers
Previous registration necessary?
Simultaneous translation ?
Will it be recorded?
Joseph C. Sweeney, George W. Foley